Cargando…

Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trial

BACKGROUND: This study aimed to investigate the efficacy and safety of subcutaneous injection of peginterferon lambda in patients hospitalized with COVID-19. METHODS: In this study (NCT04343976), patients admitted to hospital with COVID-19 confirmed by RT-PCR from nasopharyngeal swab were randomly a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Myung-Ho, Elbaz, Josh, Jilg, Nikolaus, Gustafson, Jenna L., Xu, Min, Hatipoglu, Dilara, Nohelty, Eric, Kim, Arthur Y., Chung, Raymond T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002416/ https://www.ncbi.nlm.nih.gov/pubmed/36910479 http://dx.doi.org/10.3389/fmed.2023.1095828

Ejemplares similares

Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
por: Feld, Jordan J, et al.
Publicado: (2021)

Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
por: Jagannathan, Prasanna, et al.
Publicado: (2021)

Treatment of chronic hepatitis D with peginterferon lambda—the phase 2 LIMT-1 clinical trial
por: Etzion, Ohad, et al.
Publicado: (2023)

A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C
por: Flisiak, Robert, et al.
Publicado: (2016)

Peginterferon Lambda-1a, a New Therapeutic for Hepatitis C Infection, from Bench to Clinic
por: Andersen, Henrik, et al.
Publicado: (2013)

A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3
por: Foster, Graham R., et al.
Publicado: (2016)

820 Triple Combination Treatment With Peginterferon Lambda-1a, Daclatasvir and Ribavirin for 12 Weeks in Patients Infected With HCV Genotype 1b
por: Brunetto, Maurizia, et al.
Publicado: (2014)

Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C
por: Pouresmaeeli, Mahdiyar, et al.
Publicado: (2015)

Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
por: Jung, Young Kul, et al.
Publicado: (2013)

Elasomeran/peginterferon: Autoimmune hepatitis: case report
Publicado: (2022)

A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection
por: Xiao, Nan, et al.
Publicado: (2010)

Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis
por: Kim, Kyung Hoon, et al.
Publicado: (2011)

Durability of a sustained virologic response in patients with chronic hepatitis C treated with peginterferon and ribavirin
por: Kim, Kyung-Ah
Publicado: (2011)

Clinical Characteristics and Treatment Outcome of Peginterferon Plus Ribavirin in Patients Infected with Genotype 6 Hepatitis C Virus in Korea: A Multicenter Study
por: Shin, Su Rin, et al.
Publicado: (2017)

Peginterferon based therapy for chronic hepatitis C in the elderly patients
por: Bold, Adriana, et al.
Publicado: (2013)

Cost-Efficacy Analysis of Peginterferon alfa-2b plus Ribavirin Compared With Peginterferon alfa-2a plus Ribavirin for the Treatment of Chronic Hepatitis C
por: Malone, Daniel C., et al.
Publicado: (2005)

Determination of the spin composition of $\lambda\overline{\lambda}$ and $\lambda\lambda$ ($\overline{lambda}\overline{lambda}$) pairs in hadronic Z decays
por: Lesiak, T, et al.
Publicado: (1998)

A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma
por: Brohl, Andrew S., et al.
Publicado: (2016)

Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients
por: Kim, Yun Jung, et al.
Publicado: (2012)

Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C
por: Jeong, Seok Hoo, et al.
Publicado: (2012)

The low-energy $\Lambda-N$ and $\Lambda-\Lambda$ interaction
por: Deloff, A, et al.
Publicado: (1964)

A First Measurement of the $\Lambda\overline{\Lambda}$ and $\Lambda\Lambda (\overline{\Lambda} \overline{\Lambda})$ Spin Compositions in Hadronic $Z^{0}$ Decays
por: Alexander, Gideon, et al.
Publicado: (1996)

Chronic HCV treatment with peginterferon-ribavirin and severe tuberculosis re-activation
por: Manfredi, Roberto, et al.
Publicado: (2010)

Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin
por: Yu, Ming-Lung, et al.
Publicado: (2012)

The Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian Study
por: El Raziky, Maissa, et al.
Publicado: (2013)

Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil
por: Barros, Fabio MR, et al.
Publicado: (2013)

Efficacy and Tolerability of Peginterferon α-2a and Peginterferon α-2b, Both plus Ribavirin, for Chronic Hepatitis C: A Meta-Analysis of Randomized Controlled Trials
por: Yang, Zongguo, et al.
Publicado: (2013)

Spin Correlations in the $\Lambda \Lambda$ and $\Lambda \Lambda¯$ Systems Generated in Relativistic Heavy-Ion Collisions
por: Lyuboshitz, V L, et al.
Publicado: (2010)

IL28B Alleles Exert an Additive Dose Effect When Applied to HCV-HIV Coinfected Persons Undergoing Peginterferon and Ribavirin Therapy
por: Abu Dayyeh, Barham K., et al.
Publicado: (2011)

Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C
por: Hwang, Yong, et al.
Publicado: (2015)

On the $\Lambda \overline {\Lambda }$system from the reaction $\pi ^{-} p\rightarrow \Lambda \overline {\Lambda }n$
por: Fischer, W E
Publicado: (1969)

Fermi-Dirac-correlations in $\Lambda\Lambda$ and $\overline{\Lambda} \overline{\Lambda}$ pairs in hadronic Z decays
por: Wolf, G, et al.
Publicado: (1999)

Reconstruction of the decays $\Lambda_b \to \Lambda(1115) \gamma$ and $\Lambda_b \to \Lambda(1670) \gamma$ at LHCb
por: Legger, F
Publicado: (2006)

Lambda Production and \Lambda \bar\Lambda Correlations in the Hadronic Decays of the Z
por: De Angelis, A, et al.
Publicado: (1993)

Population pharmacokinetics of peginterferon α2a in patients with chronic hepatitis B
por: Bi, Jingfeng, et al.
Publicado: (2017)

Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosis
por: Scott, Thomas F, et al.
Publicado: (2016)

Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a
por: El-Lababidi, Rania M., et al.
Publicado: (2020)

Interferon-alpha-2a/peginterferon: Various toxicities: 6 case reports
Publicado: (2022)

Expression Pattern of Cytokines in Patients with Chronic Hepatitis B Receiving PEGinterferon Therapy
por: Chen, Shao-Long, et al.
Publicado: (2023)

$\Lambda$ and $\bar{\Lambda}$ polarization at COMPASS
por: Kang, Donghee
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_n4m6oss83onvs7mkgt8k64fo23